Dehai Zhang1, Yongchun Duan1, Jing Guo2, Yaowei Wang1, Yun Yang3, Zhenhui Li4, Kelong Wang1, Lin Wu4, Minghao Yu1. 1. School of SoftwareYunnan University Kunming 650106 China. 2. School of Information Science and EngineeringYunnan University Kunming 650106 China. 3. Key Laboratory in Software Engineering of Yunnan Province, School of SoftwareYunnan University Kunming 650504 China. 4. Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center Kunming 650118 China.
Abstract
BACKGROUND: At present, radical total mesorectal excision after neoadjuvant chemoradiotherapy is crucial for locally advanced rectal cancer. Therefore, the use of histopathological images analysis technology to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer is of great significance for the subsequent treatment of patients. METHODS: In this study, we propose a new pathological images analysis method based on multi-instance learning to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Specifically, we proposed a gated attention normalization mechanism based on the multilayer perceptron, which accelerates the convergence of stochastic gradient descent optimization and can speed up the training process. We also proposed a bilinear attention multi-scale feature fusion mechanism, which organically fuses the global features of the larger receptive fields and the detailed features of the smaller receptive fields and alleviates the problem of pathological images context information loss caused by block sampling. At the same time, we also designed a weighted loss function to alleviate the problem of imbalance between cancerous instances and normal instances. RESULTS: We evaluated our method on a locally advanced rectal cancer dataset containing 150 whole slide images. In addition, to verify our method's generalization performance, we also tested on two publicly available datasets, Camelyon16 and MSKCC. The results show that the AUC values of our method on the Camelyon16 and MSKCC datasets reach 0.9337 and 0.9091, respectively. CONCLUSION: Our method has outstanding performance and advantages in predicting the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Clinical and Translational Impact Statement -This study aims to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer to assist clinicians quickly diagnose and formulate personalized treatment plans for patients.
BACKGROUND: At present, radical total mesorectal excision after neoadjuvant chemoradiotherapy is crucial for locally advanced rectal cancer. Therefore, the use of histopathological images analysis technology to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer is of great significance for the subsequent treatment of patients. METHODS: In this study, we propose a new pathological images analysis method based on multi-instance learning to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Specifically, we proposed a gated attention normalization mechanism based on the multilayer perceptron, which accelerates the convergence of stochastic gradient descent optimization and can speed up the training process. We also proposed a bilinear attention multi-scale feature fusion mechanism, which organically fuses the global features of the larger receptive fields and the detailed features of the smaller receptive fields and alleviates the problem of pathological images context information loss caused by block sampling. At the same time, we also designed a weighted loss function to alleviate the problem of imbalance between cancerous instances and normal instances. RESULTS: We evaluated our method on a locally advanced rectal cancer dataset containing 150 whole slide images. In addition, to verify our method's generalization performance, we also tested on two publicly available datasets, Camelyon16 and MSKCC. The results show that the AUC values of our method on the Camelyon16 and MSKCC datasets reach 0.9337 and 0.9091, respectively. CONCLUSION: Our method has outstanding performance and advantages in predicting the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Clinical and Translational Impact Statement -This study aims to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer to assist clinicians quickly diagnose and formulate personalized treatment plans for patients.
Entities:
Keywords:
Pervasive computing; internet of things; neoadjuvant chemoradiotherapy; pathological images; rectal cancer
Authors: Rebecca L Siegel; Kimberly D Miller; Ann Goding Sauer; Stacey A Fedewa; Lynn F Butterly; Joseph C Anderson; Andrea Cercek; Robert A Smith; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2020-03-05 Impact factor: 508.702
Authors: Ole-Johan Skrede; Sepp De Raedt; Andreas Kleppe; Tarjei S Hveem; Knut Liestøl; John Maddison; Hanne A Askautrud; Manohar Pradhan; John Arne Nesheim; Fritz Albregtsen; Inger Nina Farstad; Enric Domingo; David N Church; Arild Nesbakken; Neil A Shepherd; Ian Tomlinson; Rachel Kerr; Marco Novelli; David J Kerr; Håvard E Danielsen Journal: Lancet Date: 2020-02-01 Impact factor: 79.321
Authors: Babak Ehteshami Bejnordi; Mitko Veta; Paul Johannes van Diest; Bram van Ginneken; Nico Karssemeijer; Geert Litjens; Jeroen A W M van der Laak; Meyke Hermsen; Quirine F Manson; Maschenka Balkenhol; Oscar Geessink; Nikolaos Stathonikos; Marcory Crf van Dijk; Peter Bult; Francisco Beca; Andrew H Beck; Dayong Wang; Aditya Khosla; Rishab Gargeya; Humayun Irshad; Aoxiao Zhong; Qi Dou; Quanzheng Li; Hao Chen; Huang-Jing Lin; Pheng-Ann Heng; Christian Haß; Elia Bruni; Quincy Wong; Ugur Halici; Mustafa Ümit Öner; Rengul Cetin-Atalay; Matt Berseth; Vitali Khvatkov; Alexei Vylegzhanin; Oren Kraus; Muhammad Shaban; Nasir Rajpoot; Ruqayya Awan; Korsuk Sirinukunwattana; Talha Qaiser; Yee-Wah Tsang; David Tellez; Jonas Annuscheit; Peter Hufnagl; Mira Valkonen; Kimmo Kartasalo; Leena Latonen; Pekka Ruusuvuori; Kaisa Liimatainen; Shadi Albarqouni; Bharti Mungal; Ami George; Stefanie Demirci; Nassir Navab; Seiryo Watanabe; Shigeto Seno; Yoichi Takenaka; Hideo Matsuda; Hady Ahmady Phoulady; Vassili Kovalev; Alexander Kalinovsky; Vitali Liauchuk; Gloria Bueno; M Milagro Fernandez-Carrobles; Ismael Serrano; Oscar Deniz; Daniel Racoceanu; Rui Venâncio Journal: JAMA Date: 2017-12-12 Impact factor: 56.272
Authors: Jakob Nikolas Kather; Alexander T Pearson; Niels Halama; Dirk Jäger; Jeremias Krause; Sven H Loosen; Alexander Marx; Peter Boor; Frank Tacke; Ulf Peter Neumann; Heike I Grabsch; Takaki Yoshikawa; Hermann Brenner; Jenny Chang-Claude; Michael Hoffmeister; Christian Trautwein; Tom Luedde Journal: Nat Med Date: 2019-06-03 Impact factor: 53.440
Authors: In Ja Park; Y Nancy You; Atin Agarwal; John M Skibber; Miguel A Rodriguez-Bigas; Cathy Eng; Barry W Feig; Prajnan Das; Sunil Krishnan; Christopher H Crane; Chung-Yuan Hu; George J Chang Journal: J Clin Oncol Date: 2012-04-09 Impact factor: 44.544
Authors: Monique Maas; Patty J Nelemans; Vincenzo Valentini; Prajnan Das; Claus Rödel; Li-Jen Kuo; Felipe A Calvo; Julio García-Aguilar; Rob Glynne-Jones; Karin Haustermans; Mohammed Mohiuddin; Salvatore Pucciarelli; William Small; Javier Suárez; George Theodoropoulos; Sebastiano Biondo; Regina G H Beets-Tan; Geerard L Beets Journal: Lancet Oncol Date: 2010-08-06 Impact factor: 41.316
Authors: Drew F K Williamson; Tiffany Y Chen; Ming Y Lu; Richard J Chen; Matteo Barbieri; Faisal Mahmood Journal: Nat Biomed Eng Date: 2021-03-01 Impact factor: 25.671